Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran.

Abutorabi, Ali; Haj Ahmadi, Marjan; Bagheri Faradonbeh, Saeed; Rashki Kemmak, Asma; Alipour, Vahid

Abutorabi, Ali; Haj Ahmadi, Marjan; Bagheri Faradonbeh, Saeed; Rashki Kemmak, Asma; Alipour, Vahid.

Afiliação

Abutorabi A; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Haj Ahmadi M; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Bagheri Faradonbeh S; Department of Health Services Management, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Rashki Kemmak A; Department of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Alipour V; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Med J Islam Repub Iran ; 37: 20, 2023.

Article em En | MEDLINE | ID: mdl-37123340

Palavras-chave

Cost-Effectiveness; Enoxaparin; Knee Replacement; Rivaroxaban; Venous Thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Med J Islam Repub Iran Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google